John Thero

Mr. Thero is currently a member of the board of directors at CinCor Pharma, Inc. From 2009 until he elected to retire in August 2021, Mr. Thero was an executive officer at Amarin Corporation PLC, including being appointed President in 2010 and Chief Executive Officer and a member of its board of directors in 2014. During his tenure at Amarin, he helped successfully lead the company through clinical development, global regulatory approvals, and commercial growth. Prior to Amarin, Mr. Thero served as Chief Financial Officer at ViaCell, Inc., where he helped guide the company to its sale to PerkinElmer, and Abiomed, Inc., where he held multiple positions, including Senior Vice President of Business Operations and Chief Financial Officer. Mr. Thero began his professional career at Arthur Andersen LLP. He received a B.A. in Economics and Accounting from The College of the Holy Cross in Worcester, Massachusetts. In 2019, Mr. Thero was named Ernst & Young LLP Entrepreneur of the Year for Life Sciences.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Cyteir Therapeutics

Through a unique cancer treatment approach, Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell self destruction.


Industries

Employees

11-50

Links